Literature DB >> 19920156

Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.

Donna Sym1, Priti N Patel, Gladys M El-Chaar.   

Abstract

OBJECTIVE: To review the pathophysiology, pandemics/epidemics, transmissibility, clinical presentation, treatment, prevention/immunization, and resistance associated with seasonal, avian, and swine influenza. DATA SOURCES: Literature was obtained from MEDLINE (1966-October 2009) and International Pharmaceutical Abstracts (1971-October 2009) using the search terms influenza, seasonal influenza, avian influenza, swine influenza, H1N1, novel H1N1, H3N2, and H5N1. STUDY SELECTION AND DATA EXTRACTION: Available English-language articles were reviewed, along with information obtained from the Centers for Disease Control and Prevention, the Food and Drug Administration, and the World Health Organization. DATA SYNTHESIS: The influenza virus has caused disease in birds, swine, and humans for many centuries. Pandemics and epidemics have occurred throughout history and reports of new strains continue to emerge. Two major surface antigenic glycoproteins, hemagglutinin and neuraminidase, have various subtypes, resulting in numerous combinations of these proteins. For example, combinations occur when an influenza strain from a bird "mixes" with a strain from a human. This mixing occurs in a host, often in pigs, resulting in a new strain. This new strain can cause pandemics since people have no immunity to the new strain. An H1N1 subtype pandemic occurred in 1918, causing millions of deaths. Simultaneously, veterinary reports of "influenza" in pigs also emerged. It is postulated that humans infected pigs with this H1N1 virus. H1N1 reappeared in humans in 1976, and more recently in 2009. Other pandemics have occurred with H2N2 and H3N2 strains. In 1997, strain H5N1, which usually causes disease in fowl, was able to infect humans.
CONCLUSIONS: Influenza subtypes continue to change, causing disease in animals and humans. Utilization of immunization and antiviral treatment options are available to prevent, treat, and contain the spread of this infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920156     DOI: 10.1345/aph.1M557

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  11 in total

1.  Using sentinel surveillance system to monitor seasonal and novel H1N1 influenza infection in Houston, Texas: outcome analysis of 2008-2009 flu season.

Authors:  Salma Khuwaja; Osaro Mgbere; Adebowale Awosika-Olumo; Fayaz Momin; Katherine Ngo
Journal:  J Community Health       Date:  2011-10

2.  Clinical predictors of novel influenza A (H1N1)infection in Korea.

Authors:  Choon Ok Kim; Chung Mo Nam; Duk-Chul Lee; Sang Hoon Han; Ji Won Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

3.  A universal long-term flu vaccine may not prevent severe epidemics.

Authors:  Raffaele Vardavas; Romulus Breban; Sally Blower
Journal:  BMC Res Notes       Date:  2010-04-05

4.  Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets.

Authors:  Stephen S H Huang; David Banner; Yuan Fang; Derek C K Ng; Thirumagal Kanagasabai; David J Kelvin; Alyson A Kelvin
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

5.  The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function.

Authors:  Yuewen Ding; Lijuan Zeng; Runfeng Li; Qiaoyan Chen; Beixian Zhou; Qiaolian Chen; Pui Leng Cheng; Wang Yutao; Jingping Zheng; Zifeng Yang; Fengxue Zhang
Journal:  BMC Complement Altern Med       Date:  2017-02-24       Impact factor: 3.659

6.  The tree shrew is a promising model for the study of influenza B virus infection.

Authors:  Bing Yuan; Chunguang Yang; Xueshan Xia; Mark Zanin; Sook-San Wong; Fan Yang; Jixiang Chang; Zhitong Mai; Jin Zhao; Yunhui Zhang; Runfeng Li; Nanshan Zhong; Zifeng Yang
Journal:  Virol J       Date:  2019-06-07       Impact factor: 4.099

Review 7.  Swine Influenza (H1N1) pneumonia: clinical considerations.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2010-03       Impact factor: 5.982

Review 8.  Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.

Authors:  K Mehta; L W Goneau; J Wong; A G L'Huillier; J B Gubbay
Journal:  Curr Infect Dis Rep       Date:  2018-08-01       Impact factor: 3.725

9.  Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure.

Authors:  Stephen S H Huang; Zhen Lin; David Banner; Alberto J León; Stéphane G Paquette; Barry Rubin; Salvatore Rubino; Yi Guan; David J Kelvin; Alyson A Kelvin
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Human monoclonal antibodies broadly neutralizing against influenza B virus.

Authors:  Mayo Yasugi; Ritsuko Kubota-Koketsu; Akifumi Yamashita; Norihito Kawashita; Anariwa Du; Tadahiro Sasaki; Mitsuhiro Nishimura; Ryo Misaki; Motoki Kuhara; Naphatsawan Boonsathorn; Kazuhito Fujiyama; Yoshinobu Okuno; Takaaki Nakaya; Kazuyoshi Ikuta
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.